Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma

por Hesse, E, Musholt, P B, Potter, E, Petrich, T, Wehmeier, M, von Wasielewski, R, Lichtinghagen, R, Musholt, T J
Publicado 2005

Targeted use of intraoperative frozen-section analysis lowers the frequency of completion thyroidectomy

por Staubitz, J I, Elmrich, I, Musholt, P B, Cámara, R J A, Watzka, F, Dralle, H, Sekulla, C, Lorenz, K, Musholt, T J
Publicado 2021

P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM...

por Quach, H., Parmar, G., Ocio, E. M., Prince, H. M., Oriol, A., Tsukada, N., Sunami, K., Bories, P., Karanes, C., Madan, S., Semiond, D., Inchauspe, M., Macé, S., Musholt, P. B., Suzan, F., Moreau, P.
Publicado 2022